HASHICORP INC-CL A (HCP) Stock Fundamental Analysis
USA - NASDAQ:HCP - US4181001037 - Common Stock
34.78 USD
-0.03 (-0.09%)
34.98 USD
+0.2 (+0.58%)
HCP gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 281 industry peers in the Software industry. HCP has a great financial health rating, but its profitability evaluates not so good. HCP is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
HCP had positive earnings in the past year.
In the past year HCP had a positive cash flow from operations.
In the past 5 years HCP always reported negative net income.
In the past 5 years HCP always reported negative operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -7.22%, HCP is in line with its industry, outperforming 43.11% of the companies in the same industry.
With a Return On Equity value of -9.72%, HCP perfoms like the industry average, outperforming 49.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.22% | ||
| ROE | -9.72% | ||
| ROIC | N/A |
ROA(3y)-15.33%
ROA(5y)-17.17%
ROE(3y)-20.37%
ROE(5y)-30.92%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
HCP's Gross Margin of 82.09% is amongst the best of the industry. HCP outperforms 86.93% of its industry peers.
In the last couple of years the Gross Margin of HCP has remained more or less at the same level.
HCP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 82.09% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.31%
GM growth 5Y-0.29%
2. Health
2.1 Basic Checks
HCP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HCP has more shares outstanding
There is no outstanding debt for HCP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 9.80 indicates that HCP is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 9.80, HCP belongs to the top of the industry, outperforming 85.87% of the companies in the same industry.
There is no outstanding debt for HCP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 9.8 |
ROIC/WACCN/A
WACC13.94%
2.3 Liquidity
A Current Ratio of 3.79 indicates that HCP has no problem at all paying its short term obligations.
HCP has a better Current ratio (3.79) than 81.63% of its industry peers.
HCP has a Quick Ratio of 3.79. This indicates that HCP is financially healthy and has no problem in meeting its short term obligations.
HCP has a Quick ratio of 3.79. This is amongst the best in the industry. HCP outperforms 81.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.79 | ||
| Quick Ratio | 3.79 |
3. Growth
3.1 Past
HCP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 247.62%, which is quite impressive.
HCP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.30%.
Measured over the past years, HCP shows a very strong growth in Revenue. The Revenue has been growing by 61.00% on average per year.
EPS 1Y (TTM)247.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%333.33%
Revenue 1Y (TTM)16.3%
Revenue growth 3Y40.14%
Revenue growth 5Y61%
Sales Q2Q%18.66%
3.2 Future
Based on estimates for the next years, HCP will show a very strong growth in Earnings Per Share. The EPS will grow by 118.92% on average per year.
HCP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.37% yearly.
EPS Next Y509.24%
EPS Next 2Y171.61%
EPS Next 3Y118.92%
EPS Next 5YN/A
Revenue Next Year16.96%
Revenue Next 2Y15.67%
Revenue Next 3Y15.37%
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
HCP is valuated quite expensively with a Price/Earnings ratio of 112.19.
HCP's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of HCP to the average of the S&P500 Index (25.89), we can say HCP is valued expensively.
With a Price/Forward Earnings ratio of 71.87, HCP can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as HCP.
The average S&P500 Price/Forward Earnings ratio is at 34.59. HCP is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 112.19 | ||
| Fwd PE | 71.87 |
4.2 Price Multiples
The rest of the industry has a similar Price/Free Cash Flow ratio as HCP.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 124.32 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
HCP's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as HCP's earnings are expected to grow with 118.92% in the coming years.
PEG (NY)0.22
PEG (5Y)N/A
EPS Next 2Y171.61%
EPS Next 3Y118.92%
5. Dividend
5.1 Amount
No dividends for HCP!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
34.78
-0.03 (-0.09%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners79.69%
Inst Owner Change-2.85%
Ins Owners3.97%
Ins Owner Change0%
Market Cap7.11B
Revenue(TTM)654.89M
Net Income(TTM)-122.22M
Analysts52
Price Target35.32 (1.55%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1179.36%
Min EPS beat(2)163.27%
Max EPS beat(2)2195.45%
EPS beat(4)4
Avg EPS beat(4)814.28%
Min EPS beat(4)163.27%
Max EPS beat(4)2195.45%
EPS beat(8)8
Avg EPS beat(8)447.11%
EPS beat(12)12
Avg EPS beat(12)310.7%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)4.35%
Min Revenue beat(2)3.98%
Max Revenue beat(2)4.72%
Revenue beat(4)4
Avg Revenue beat(4)3.95%
Min Revenue beat(4)3.32%
Max Revenue beat(4)4.72%
Revenue beat(8)8
Avg Revenue beat(8)3.78%
Revenue beat(12)12
Avg Revenue beat(12)5.75%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.2%
EPS NQ rev (1m)-2.58%
EPS NQ rev (3m)22.03%
EPS NY rev (1m)0%
EPS NY rev (3m)42.14%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)1.25%
Revenue NY rev (1m)-0.24%
Revenue NY rev (3m)1.53%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 112.19 | ||
| Fwd PE | 71.87 | ||
| P/S | 10.86 | ||
| P/FCF | 124.32 | ||
| P/OCF | 104.53 | ||
| P/B | 5.65 | ||
| P/tB | 5.75 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.31
EY0.89%
EPS(NY)0.48
Fwd EY1.39%
FCF(TTM)0.28
FCFY0.8%
OCF(TTM)0.33
OCFY0.96%
SpS3.2
BVpS6.15
TBVpS6.05
PEG (NY)0.22
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.22% | ||
| ROE | -9.72% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 82.09% | ||
| FCFM | 8.73% |
ROA(3y)-15.33%
ROA(5y)-17.17%
ROE(3y)-20.37%
ROE(5y)-30.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.31%
GM growth 5Y-0.29%
F-Score6
Asset Turnover0.39
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 84.44% | ||
| Cap/Sales | 1.65% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.79 | ||
| Quick Ratio | 3.79 | ||
| Altman-Z | 9.8 |
F-Score6
WACC13.94%
ROIC/WACCN/A
Cap/Depr(3y)195.54%
Cap/Depr(5y)361.24%
Cap/Sales(3y)2%
Cap/Sales(5y)2.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)247.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%333.33%
EPS Next Y509.24%
EPS Next 2Y171.61%
EPS Next 3Y118.92%
EPS Next 5YN/A
Revenue 1Y (TTM)16.3%
Revenue growth 3Y40.14%
Revenue growth 5Y61%
Sales Q2Q%18.66%
Revenue Next Year16.96%
Revenue Next 2Y15.67%
Revenue Next 3Y15.37%
Revenue Next 5YN/A
EBIT growth 1Y37.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year118.63%
EBIT Next 3Y44.51%
EBIT Next 5YN/A
FCF growth 1Y156.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y173.12%
OCF growth 3YN/A
OCF growth 5YN/A
HASHICORP INC-CL A / HCP FAQ
What is the ChartMill fundamental rating of HASHICORP INC-CL A (HCP) stock?
ChartMill assigns a fundamental rating of 5 / 10 to HCP.
What is the valuation status of HASHICORP INC-CL A (HCP) stock?
ChartMill assigns a valuation rating of 3 / 10 to HASHICORP INC-CL A (HCP). This can be considered as Overvalued.
What is the profitability of HCP stock?
HASHICORP INC-CL A (HCP) has a profitability rating of 2 / 10.
Can you provide the PE and PB ratios for HCP stock?
The Price/Earnings (PE) ratio for HASHICORP INC-CL A (HCP) is 112.19 and the Price/Book (PB) ratio is 5.65.
What is the financial health of HASHICORP INC-CL A (HCP) stock?
The financial health rating of HASHICORP INC-CL A (HCP) is 8 / 10.